Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
Top Cited Papers
- 8 July 2026
- journal article
- review article
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 14 (9) , 754-777
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- National Institute for Health and Care Research
- Rosetrees Trust
This publication has 187 references indexed in Scilit:
- World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in AdultsJAMA, 2026
- Integrating Diet and Physical Activity When Prescribing GLP-1s—Lifestyle Factors Remain CrucialJAMA Internal Medicine, 2025
- Once-Weekly Semaglutide in Adults With Alcohol Use DisorderJAMA Psychiatry, 2025
- Screening for Osteoporosis to Prevent FracturesJAMA, 2025
- Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and SuicidalityJAMA Network Open, 2024
- Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination TreatmentJAMA Network Open, 2024
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or ObesityJAMA, 2021
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or ObesityJAMA, 2021
- The Physical Activity Guidelines for AmericansJAMA, 2018
- Substance Use Following Bariatric Weight Loss SurgeryJAMA Surgery, 2013